A trial looking at treatment for children with anaplastic large cell lymphoma (ALCL-Relapse, NHL 2006 01)

Cancer type:

Blood cancers
Children's cancers
High grade lymphoma
Lymphoma
Non-Hodgkin lymphoma

Status:

Results

Phase:

Phase 3

This trial looked at chemotherapy for children with a type of non Hodgkin lymphoma called anaplastic large cell lymphoma (ALCL) that had not responded to treatment or had come back after treatment. The trial was for children and young people up to the age of 22.

ALCL is a rare type of high grade non Hodgkin lymphoma. Children and young people with ALCL usually have treatment with a combination of different chemotherapy drugs. But for a very small number of children, the treatment does not work or their ALCL comes back later (relapses Open a glossary item).

The aims of this study were to

  • See if chemotherapy and a stem cell transplant improved the outcome for children and young people who had relapsed ALCL
  • Find out the effect of a drug called vinblastine in children and young people who hadn’t had this drug as part of their initial treatment

Summary of results

This trial closed in the UK as very few patients were recruited.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Dr Denise Williams

Supported by

Children's Cancer and Leukaemia Group (CCLG)
National Institute for Health Research Cancer Research Network (NCRN)

Questions about cancer? Contact our information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 764

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Charlie took part in a trial to try new treatments

A picture of Charlie

“I think it’s really important that people keep signing up to these type of trials to push research forward.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think